Groundbreaking Randomized MASAI Trial Demonstrates Transpara® plays a vital role in improving early detection, leading to better outcomes and more efficient use of radiologist time
NIJMEGEN, The Netherlands, Feb. 5, 2025 /PRNewswire/ — Results of a groundbreaking, randomized trial involving more than 105,000 women reveals that the use of artificial intelligence (AI) in mammography screening significantly increases cancer detection rates while reducing the workload for radiologists.
Published in The Lancet Digital Health, the Mammography Screening with Artificial Intelligence (MASAI) trial, conducted within the Swedish national screening program, demonstrates that Transpara®-assisted workflow increased cancer detection by 29% and resulted in a 44%…